A detailed history of Sc&H Financial Advisors, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Sc&H Financial Advisors, Inc. holds 1,169 shares of ABBV stock, worth $213,845. This represents 0.05% of its overall portfolio holdings.

Number of Shares
1,169
Previous 1,167 0.17%
Holding current value
$213,845
Previous $200,000 15.0%
% of portfolio
0.05%
Previous 0.05%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

BUY
$163.84 - $199.33 $327 - $398
2 Added 0.17%
1,169 $230,000
Q2 2024

Aug 01, 2024

BUY
$154.79 - $180.76 $180,639 - $210,946
1,167 New
1,167 $200,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $323B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Sc&H Financial Advisors, Inc. Portfolio

Follow Sc&H Financial Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sc&H Financial Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Sc&H Financial Advisors, Inc. with notifications on news.